A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Albany College of Pharmacy and Health Sciences

Status and phase: Completed; Phase 4

Conditions: Obesity

Treatments: Drug: Orlistat

Study type: Interventional

Funder types: Other

Identifiers

NCT01035333

09-016

Details and patient eligibility

About

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Enrollment: 19 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patients preparing for gastric bypass surgery

Exclusion criteria

• pregnancy

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

19 participants in 1 patient group

orlistat 60mg

Experimental group

Description:

Patients assigned to treatment group for up to 6 months of therapy.

Treatment:

Drug: Orlistat